You are reading the October 2026 edition. Get the current edition for this market — $99/year →

Labor Market Pulse

SD NONMETROPOLITAN AREA Edition

Focus: LIFE SCI

Nonmetro SD clinical pay surges as regulatory work shifts elsewhere.

2.0%-2.1%

SD statewide unemployment

vs 4.1% national rate, Sept 2026

66.5%

Labor force participation

Down 1.7 pts YoY; 7th highest nationally

-900 (Aug)

SD private-sector jobs

vs +162,000 US nonfarm payrolls

$114,430 metro

CRA advertised pay premium

vs $90,956 national median

This Month's Takeaways

01

Declining nonmetro pay for regulatory roles may mask outsourcing, not weakness.

Regulatory Affairs Specialist advertised pay fell to $81,143 locally versus a stable $104,000 nationally, a wide enough gap to suggest complex regulatory work is increasingly handled by national firms or CROs rather than local hires. Treat this spread as a build-vs-outsource signal, not evidence that regulatory talent has gotten cheaper to retain.

02

Clinical research pay is pulling sharply ahead of national rates.

Clinical Research Associate advertised pay reached $114,430 locally against a $90,956 national median, a premium that is hard to explain through cost of living alone. Current conditions suggest real local scarcity in clinical operations talent, likely compounded by the region's shrinking labor force participation.

03

Biostatistician pay divergence signals this skillset barely exists locally.

Local Biostatistician pay sits at $74,360 against a national median of $133,322 — nearly half. This gap is consistent with a near-total absence of a resident biostatistics labor pool, reinforcing that statistical and data-heavy clinical functions are strong candidates for remote hiring or CRO partnership rather than local build-out.

04

Quality leadership hiring shows capital commitment despite soft headline jobs numbers.

Novartis's advertised VP Quality Assurance role at $275K-$310K, requiring 15+ years of biotech/pharma experience, stands out against a state that lost 900 private-sector jobs in August. Senior quality and scientific hiring appears insulated from broader nonmetro labor softening, reflecting committed manufacturing or development investment rather than headcount caution.

Nonmetro South Dakota's labor market stays functionally tight — statewide unemployment sits near 2.0%-2.1% with labor force participation at 66.5%, down 1.7 points year-over-year, even as the state shed 900 private-sector jobs in August against a national gain of 162,000. For Life Sci employers outside Sioux Falls and Rapid City, this combination of scarce workers and softening headline job counts points to a market where hiring is constrained less by weak demand than by a shrinking pool of credentialed, mobile talent.

Falling participation alongside flat-to-declining advertised pay for roles like Regulatory Affairs Specialist and Biostatistician locally suggests employers are either filling specialized seats remotely or relying on CRO/CDMO partners rather than competing head-on for scarce nonmetro talent. Novartis's active recruiting for Principal Scientists and VP Quality Assurance signals that larger, capital-backed employers are still willing to pay premiums for senior scientific and quality leadership even as broader nonmetro hiring cools. Organizations should evaluate whether declining local advertised pay for regulatory and biostatistics roles reflects genuine market softening or a shift of that work toward outsourced or remote arrangements that nonmetro postings no longer capture.

Advertised Pay Indicators

Role P25 Median P75 Local Trend National Nat. Trend
Research Scientist $109,700 $135,141 $135,141 ↑ Significant increase $131,354 ↑ Significant increase
Clinical Research Associate $70,714 $114,430 $119,546 ↑ Significant increase $90,956 ↑ Significant increase
Lab Technician $38,403 $48,830 $50,921 ↑ Significant increase $47,402 ↓ Moderate decline
Regulatory Affairs Specialist $75,529 $81,143 $89,022 ↓ Moderate decline $104,000 → Stable
Clinical Data Manager $99,344 $111,806 $114,422 ↓ Significant decline $123,031 ↓ Moderate decline
Biostatistician $58,356 $74,360 $108,363 ↓ Significant decline $133,322 ↑ Moderate increase
Validation Engineer — — — — No data $108,377 ↑ Moderate increase

Some roles reflect state-level data where local metro sample size was insufficient.

Looking Ahead · Next 30–60 Days

Worth watching

South Dakota's September BLS unemployment release lands October 20; a move off the 2.0%-2.1% range would be the first real signal of labor supply loosening in the nonmetro area this year.

Emerging pressure point

Labor force participation has fallen 1.7 points year-over-year even as unemployment stays near historic lows — watch whether this gap widens, which would tighten the credentialed talent pool further and sharpen build-vs-outsource tradeoffs.

Potential inflection point

Discovery District's 2,800-worker, 25-year life sciences buildout offers no near-term relief, but early hiring signals or facility announcements tied to it over the next two months would be the first concrete markers of future local supply.

Early indicator

National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions; watch whether any released regulatory, quality or clinical talent shows interest in remote or relocation-based nonmetro roles, easing scarcity in CRA and quality hiring.

WageScape Member Benefit

Monitor more markets, industries, and job families.

Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.

Pulse Plus

3 metro reports

$149/year

Pulse Pro

10 metro reports

$349/year

Enterprise

10+ markets

Contact us

WageTrak · 15% Member Discount

On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.

Forwarded This Briefing?

Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.